Abstract: Prostaglandin E 2 (PGE 2 ) is generated in various cells, including endothelial cells, and is responsible for various functions, such as vascular relaxation and angiogenesis. Effects of PGE 2 are mediated via receptors EP1-EP4, among which EP2 and EP4 are coupled to Gs protein which activates adenylate cyclase (AC) and cAMP synthesis. The aim of this work was to study the ability of human microvascular endothelial cells (HMEC-1) to synthesize cAMP in the presence of PGE 2 , and to determine the effect of hypoxia on the PGE 2 -stimulated cAMP level. It was decided to evaluate the effect of PGE 2 on the secretion of VEGF, an inducer of angiogenesis. In summary, our findings show that PGE 2 induces cAMP production, but hypoxia may impair PGE 2 -stimulated activity of the AC-cAMP signaling pathway. These results suggest that the cardioprotective effect of PGE 2 /EP4/cAMP may be attenuated during ischemia. Furthermore, this study indicates that the pro-angiogenic effect of PGE 2 is not associated with VEGF secretion in HMEC-1 cells.
INTRODUCTION
The endothelium represents the inner cellular lining of blood vessels and is composed of endothelial cells (ECs) displaying phenotypic and functional heterogeneity that is dependent on the species, organ, and vascular bed, as well as the different populations of receptors present on their cell membranes [1, 2] . Among the various receptors present are β-adrenoceptors and adenosine A 2 -type receptors that are positively coupled to the adenylyl cyclase/adenosine-3',5' cyclic monophosphate (cAMP) signaling system [3] [4] [5] . Prostaglandin E 2 (PGE 2 ) is generated from arachidonic acid by COX-1 or COX-2 (cyclooxygenase converts to PGG 2 and further reduces to PGH 2 ) and specific prostanoid synthases in various cells, including endothelial cells [6] . The biological effects of PGE 2 are mediated by four EP receptors that are coupled to different G proteins. EP1 is associated with Gq protein which activates phospholipase Cβ. EP3 is coupled to Gi and inhibits action of adenylate cyclase and cAMP formation. EP2 and EP4 signal predominantly via Gs, thereby elevating intracellular cAMP levels through the action of adenylate cyclase [6, 7] . PGE 2 is responsible for formation of cAMP by the endothelium, which stimulates cAMP-PKA-dependent activation of eNOS by PP1C (protein phosphatase 1C) involved in the dephosphorylation at Thr 495 , and this mechanism is responsible for vascular relaxation [8] . The aim of this work was to study the ability of human microvascular endothelial cells (HMEC-1) to synthesize cAMP in the presence of PGE 2 , and to determine the effect of hypoxia on the PGE 2 -stimulated cAMP level. It was decided to evaluate the effect of PGE 2 on the secretion of VEGF, inducer of angiogenesis.
MATERIALS AND METHODS

Chemicals
The following substances were used: MCDB 131 medium, fetal bovine serum, penicillin-streptomycin solution (5,000 units/ml penicillin and 5,000 μg/ml streptomycin sulfate in normal saline), phosphate buffered saline (PBS; pH 7.4) and trypsin-EDTA (0.25% trypsin, 1 mM EDTA-4 Na) were purchased from Invitrogen (Carlsbad, CA, USA). Cobalt chloride, human EGF, hydrocortisone, prostaglandin E 2 (dinoprostone), and 3-isobutyl-1-methylxanthine (IBMX) were purchased from Sigma Chemical Co. (St. Louis, USA 3 flasks in MCDB 131 medium supplemented with 10% fetal bovine serum, 10 ng/ml epidermal growth factor, 1 μg/ml hydrocortisone and penicillin-streptomycin solution, in a humidified atmosphere of 95% and 5% CO 2 at 37°C. Cells were harvested every third day in a trypsin-EDTA solution (0.25% trypsin, 1 mmol/l EDTA). HMEC-1 cells were cultured according to the method described in the literature [3, 9] and the author's own modification.
Assay of cAMP formation
Cells used in experiments were seeded in 12-well plates at a density of 250,000 cells/well in 500 µl of culture medium and cultured overnight. The next day, the culture medium was removed, fresh serum-free culture medium was added, and cells were incubated in the presence of ( 3 H) adenine for 2 h at 37°C. Next, the medium was removed, cells were rinsed twice with pre-warmed phosphate-buffered saline (PBS) and serum-free culture was added. Then, cells were preincubated for 20 min at 37°C in the presence of the PDE (phosphodiesterase) inhibitor 3-isobutyl-1-methylxanthine (IBMX; 0.1 mmol/l). After this preincubation period, cells were exposed to appropriate agonists for a further 15 min. The reaction was stopped by adding 500 µl of ice-cold 10% trichloroacetic acid. The resulting mixture was then transferred into tubes, centrifuged and the formed cAMP was quantified in a supernatant fraction. The formation of ( 3 H) cAMP in ( 3 H)adenine prelabeled cells was assayed according to Shimizu et al. [10] . The formed ( 3 H)cyclic AMP was isolated by sequential Dowex-alumina column chromatography according to Salomon et al. [11] . The results were individually corrected for percentage recovery with the aid of ( 14 C) cAMP added to each column system prior to the nucleotide extraction. The accumulation of cAMP during a 15-min stimulation period was assessed as a percentage of the conversion of ( 3 H)adenine to ( 3 H) cAMP. Details of the whole procedure were described previously [12] .
ELISA assays VEGF concentrations in cell culture media were determined by commercially available ELISA kits according to the vendor's protocols (R&D System, Abingdon, UK).
Data analysis
All data were presented as means ± SD (standard deviation). Statistical comparisons between the groups were performed using ANOVA, and post-hoc comparisons were performed using the Student-Newman-Keuls test. The normal distribution of parameters was checked by means of the Shapiro-Wilk test. If the data were not normally distributed or the values of the variance (F test) were different, ANOVA with the Kruskal-Wallis and Mann-Whitney U test were used. All parameters were considered significantly different if p < 0.05. The statistical data analysis was performed using Statistica 10.0 software.
RESULTS
In the present study, we confirmed the powerful action of PGE 2 (10 -11 -10 -5 mol/l) on cAMP formation in HMEC-1 cells (Fig. 1) . PGE 2 stimulated the cAMP generating system in a concentration-dependent manner. The strongest effect of PGE 2 was observed at a concentration of 10 -5 mol/l (by 1082%) and then successively 10 -6 mol/l (by 762%), 10 -7 mol/l (by 527%), and 10 -8 mol/l (by 287%). The results were statistically significant (p < 0.05). -5 mol/l) was studied (Fig. 2) . The hypoxia diminished the PGE 2 -stimulated AC-cAMP signaling pathway. PGE 2 stimulated the cAMP generating system in a concentration-dependent manner under hypoxic conditions, but the levels of cAMP were significantly lower (p < 0.05) than in normoxia. The biggest difference was observed between hypoxia and normoxia at a concentration of 10 -5 mol/l (by 67%), and then 10 -6 (by 57%) and 10 -7 mol/l (by 48%). The results were statistically significant (p < 0.05). In the next stage of the study, the effect of duration of hypoxia on (10 -5 mol/l) PGE 2 -induced cAMP level was determined (Fig. 3) . Endothelial cells' incubation with cobalt chloride (200 µmol/l) for 1 hour and 3, 6, 12 and 24 hours weakened the formation of PGE 2 -induced cAMP (10 -5 mol/l). The observed results were statistically significant (p < 0.05). In the last series of experiments, the effects of PGE 2 (10 -7 -10 -5 mol/l) on VEGF level in HMEC-1 cells were observed (Fig. 4) . 200 µmol/l cobalt chloride induced VEGF production in a statistically significant manner. However, PGE 2 (10 -7 -10 -5 mol/l) did not stimulate VEGF secretion. 
DISCUSSION
Our previous studies conducted on human microvascular endothelial cells (HMEC-1) and human umbilical vein endothelial cells (HUVEC) have shown that adrenaline, isoprenaline and noradrenaline (via the β-adrenoceptor) and NECA (5'-(N-ethylcarboxamido)adenosine) via the A2-type receptor and forskolin (a direct activator of adenylyl cyclase) are capable of strongly stimulating the production of cAMP in this cell system [3] [4] [5] . Therefore, we decided to extend these studies of the effect of PGE 2 to adenylyl cyclase (AC)-cAMP signaling and any functional response in HMEC-1. In the present work, PGE 2 (10 -11 -10 -5 mol/l) in a concentration-dependent manner stimulated the cAMP generating system in microvessel-derived endothelial cells (Fig. 1) . The increase in cAMP levels, resulting from the action of PGE 2 , was statistically significant from a concentration of 10 -8 to 10 -5 mol/l. Endothelial cells contain receptors for prostaglandins. PGE 2 causes an increase of cAMP level by activating EP2 and EP4 receptors that belong to the family of G s protein-coupled receptors [6] . The data indicate that PGE 2 evokes vasorelaxation through formation of cAMP and it activates eNOS by (protein phosphatase 1C) PP1C-mediated dephosphorylation at Thr 495 in cultured endothelial cells [8] . Receptors responsible for vasorelaxation are EP2 and especially EP4. HMEC-1 cells were subjected to hypoxic conditions (200 µmol/l CoCl 2 for 24 h) under which the cell system was tested for its ability to generate cAMP in response to PGE 2 (10 -7 -10 -5 mol/l) (Fig. 2) . HMEC-1 cells appeared to be highly sensitive to hypoxic conditions (lasting 1, 3, 6, 12 and 24 hours), and their cAMP responses to PGE 2 were dramatically suppressed (Fig. 3) . A similar debilitating effect of cAMP synthesis was observed in the presence of adrenaline in HMEC-1 cells in our previous studies [4] . The results may indicate a weakening vasorelaxation PGE 2 effect in hypoxia and/or ischemia. Positive effects of PGE 2 result most likely increase the synthesis of cAMP in a soluble fraction of cardiomyocytes, and it can lead to attenuation of cardiac ischemiareperfusion injury [13] . In the present of study it was shown that the effect of PGE 2 -mediated cAMP generation via EP4 can be weakened during ischemia. Nowadays, NSAIDs are frequently discussed in the context of the risk of cardiotoxicity and the possibility of causing a myocardial infarction [14] . Therefore NSAIDs, both selective and non-selective COX-2 inhibitors such as diclofenac and ibuprofen, may exacerbate ischemic heart disease by reducing PGE 2 production [13] . In addition, in our previous studies, NSAIDs (valdecoxib, diclofenac, ibuprofen) reduced the levels of bFGF under inflammatory conditions in HMEC-1 cells [15, 16] . bFGF promotes regeneration after myocardial infarction and thereby improves the cardiac function [17, 18] . It seems, according to the evidence, that NSAIDs can in different, adverse ways affect the cardiovascular system, via reduction of PGE 2 synthesis and reduction of bFGF secretion, especially under hypoxia and inflammatory conditions. PGE 2 at concentrations of 10 -7 -10 -5 mol/l did not stimulate VEGF secretion (Fig. 4) . A similar, measurable effect of PGE 2 on the expression of VEGF was not observed in another study in neonatal human dermal microvascular endothelial cells [19] . In our previous studies, adrenaline and forskolin did not evoke VEGF secretion in HMEC-1 [3] . These results suggest that cAMP is not related to the stimulation of VEGF secretion in HMEC-1 cells. Despite the lack of effect of PGE 2 on VEGF production, it does not mean that PGE 2 does not promote angiogenesis. Some data demonstrate that PGE 2 plays a role in regulating endothelial cell proliferation, migration, and tubulogenesis [19, 20] . Zhang and Daaka have shown that EP4 receptor agonists mediate angiogenesis in a cAMP/PKA/eNOS/cGMP-associated manner in human endothelial cells [19] . Hypoxia and inflammation (which is connected with PGE 2 ) can regulate angiogenesis via different factors, such as reactive oxygen species, cytokines, chemokines and microRNA, in pathological events (cardiovascular disorders, solid tumors) [21, 22] . In summary, our findings show that PGE 2 induces cAMP production, but hypoxia may impair PGE 2 -stimulated activity of the AC-cAMP signaling pathway. These results suggest that the cardioprotective effect of PGE 2 /EP4/cAMP may be attenuated during ischemia. Furthermore, this study indicates that the pro-angiogenic effect of PGE 2 is not associated with VEGF secretion in HMEC-1 cells.
